Search Results - SCSK~

Refine Results
  1. 1

    Mechanical impact in disk mill for producing controlled rice husk particle size by changing impactor shapes and disk rotation speeds by Nandiyanto, Asep Bayu Dani, Ragadhita, Risti, Sukmafitri, Ajeng, Muhammad Roil Bilad, Muhammad Aziz, Jumril Yunas

    Published 2020
    “…The impactor sizes and shapes influenced the contact diameter and area of impactor for making more materials being collided, whereas disk rotation speed led to giving more collision number (between rice husk and impactor) and increasing impact from the collision (due to less time contact during collision). …”
    Get full text
    Get full text
  2. 2

    Targeting PCSK9 for hypercholesterolemia by Norata, Giuseppe, Tibolla, G., Catapano, A.

    Published 2014
    “…The observation that proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates the levels of circulating low-density lipoprotein C (LDL-C) by enhancing the degradation of the hepatic low-density lipoprotein receptor (LDLR) prompted the search for drugs that inhibit PCSK9 activity. …”
    Get full text
  3. 3

    SCSA: Evaluating skyline queries in incomplete data by Gulzar, Yonis, Alwan, Ali Amer, Mohamed Abdullah, Radhwan, Xin, Qin, Swidan, Marwa

    Published 2019
    “…In order to address these issues, we propose a new skyline algorithm called Sorting-based Cluster Skyline Algorithm (SCSA) that combines the sorting and partitioning techniques and simplifies the skyline computation on an incomplete dataset. …”
    Get full text
    Get full text
    Get full text
    Get full text
  4. 4

    PCSK9 inhibitors and dyslipidemia: The clinical evidence by Norata, Giuseppe

    Published 2014
    “…The inhibition of PCSK9 favors LDL catabolism and reduces plasma LDL-C levels. …”
    Get full text
  5. 5

    PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges by Norata, Giuseppe, Tibolla, G., Catapano, A.

    Published 2014
    “…These findings led to the development of PCSK9 inhibitors. Anti-PCSK9 monoclonal antibodies showed encouraging results and are currently being evaluated in phase III clinical trials. …”
    Get full text
  6. 6

    Characteristics for Performance Optimization of Safety-Critical System Development (SCSD) by Ahmed Thawaba, Abdulaziz, Ramli, Azizul Azhar, Md Fudzee, Mohd Farhan, Wadata, Junzo

    Published 2020
    “…This paper proposed a guideline that helps developers reduce the causes of failure during SCS development. This guide has four characteristics, each with a role in improving SCSD and reducing causes of failure.…”
    Get full text
    Get full text
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20